| A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms D Olcaydu, A Harutyunyan, R Jäger, T Berg, B Gisslinger, I Pabinger, ... Nature genetics 41 (4), 450-454, 2009 | 433 | 2009 |
| Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms JD Milosevic Feenstra, H Nivarthi, H Gisslinger, E Leroy, E Rumi, ... Blood, The Journal of the American Society of Hematology 127 (3), 325-332, 2016 | 305 | 2016 |
| Capture Hi-C identifies the chromatin interactome of colorectal cancer risk loci R Jäger, G Migliorini, M Henrion, R Kandaswamy, HE Speedy, A Heindl, ... Nature communications 6 (1), 6178, 2015 | 239 | 2015 |
| Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression T Klampfl, A Harutyunyan, T Berg, B Gisslinger, M Schalling, K Bagienski, ... Blood, The Journal of the American Society of Hematology 118 (1), 167-176, 2011 | 207 | 2011 |
| Deletions of the transcription factor Ikaros in myeloproliferative neoplasms R Jäger, H Gisslinger, F Passamonti, E Rumi, T Berg, B Gisslinger, ... Leukemia 24 (7), 1290-1298, 2010 | 180 | 2010 |
| The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms D Olcaydu, E Rumi, A Harutyunyan, F Passamonti, D Pietra, C Pascutto, ... Haematologica 96 (3), 367, 2011 | 84 | 2011 |
| Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F FX Schaub, R Jäger, R Looser, H Hao-Shen, S Hermouet, F Girodon, ... Blood, The Journal of the American Society of Hematology 113 (9), 2022-2027, 2009 | 83 | 2009 |
| Thrombopoietin receptor is required for the oncogenic function of CALR mutants H Nivarthi, D Chen, C Cleary, B Kubesova, R Jäger, E Bogner, C Marty, ... Leukemia 30 (8), 1759-1763, 2016 | 72 | 2016 |
| Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms F Schischlik, R Jäger, F Rosebrock, E Hug, M Schuster, R Holly, E Fuchs, ... Blood, The Journal of the American Society of Hematology 134 (2), 199-210, 2019 | 64 | 2019 |
| Germline RBBP6 mutations in familial myeloproliferative neoplasms AS Harutyunyan, R Giambruno, C Krendl, A Stukalov, T Klampfl, T Berg, ... Blood, The Journal of the American Society of Hematology 127 (3), 362-365, 2016 | 63 | 2016 |
| Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms R Jäger, AS Harutyunyan, E Rumi, D Pietra, T Berg, D Olcaydu, ... American journal of hematology 89 (12), 1107-1110, 2014 | 58 | 2014 |
| visPIG-a web tool for producing multi-region, multi-track, multi-scale plots of genetic data M Scales, R Jäger, G Migliorini, RS Houlston, MYR Henrion PloS one 9 (9), e107497, 2014 | 43 | 2014 |
| MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia M Clarke, S Dumon, C Ward, R Jäger, S Freeman, B Dawood, L Sheriff, ... Leukemia 27 (3), 661-670, 2013 | 30 | 2013 |
| Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera R Jäger, H Gisslinger, E Fuchs, E Bogner, JD Milosevic Feenstra, ... Blood, The Journal of the American Society of Hematology 137 (3), 387-391, 2021 | 18 | 2021 |
| Molecular pathogenesis of Philadelphia chromosome negative chronic myeloproliferative neoplasms R Jager, R Kralovics Current Cancer Drug Targets 11 (1), 20-30, 2011 | 18 | 2011 |
| Molecular basis and clonal evolution of myeloproliferative neoplasms R Jäger, R Kralovics Haematologica 95 (4), 526, 2010 | 15 | 2010 |
| PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms JD Milosevic Feenstra, R Jäger, F Schischlik, D Ivanov, G Eisenwort, ... American Journal of Hematology 97 (4), 390-400, 2022 | 11 | 2022 |
| Deletions of the Transcription Factor Ikaros in Myeloproliferative Neoplasms at Transformation to Acute Myeloid Leukemia. R Jäger, H Gisslinger, T Berg, F Passamonti, M Cazzola, E Rumi, D Pietra, ... Blood 114 (22), 435, 2009 | 9 | 2009 |
| Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia C Kornauth, C Herbaux, B Boidol, C Guillemette, P Caron, ME Mayerhöfer, ... haematologica 106 (8), 2251, 2021 | 7 | 2021 |
| Multimodality imaging beyond CLEM: Showcases of combined in-vivo preclinical imaging and ex-vivo microscopy to detect murine mural vascular lesions K Keuenhof, P Heimel, LM Zopf, M Raigel, A Turyanskaya, A Kavirayani, ... Methods in cell biology 162, 389-415, 2021 | 7 | 2021 |
